Biosimilars play an increasingly important role in the expanding global market for biotech medicines; and, navigating the challenges of developing a biosimilar through clinical trials while meeting regulatory guidelines requires an experienced partner. Q2
Solutions’ immunoassay services
has experience developing, transferring and validating nonclinical and clinical assays to support biosimilar studies, including quantitative, immunogenicity and biomarkers assays.
Download our factsheet to learn more about our specific bioanalytic biosimilar capabilities